Variant report
Variant | nsv1052482 |
---|---|
Chromosome Location | chr13:66662516-66696659 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538832151 | chr13:66662553-66662554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs375829703 | chr13:66662556-66662557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546531965 | chr13:66662571-66662572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573748387 | chr13:66666613-66666614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370194083 | chr13:66666618-66666619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs58613882 | chr13:66666672-66666673 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs559822130 | chr13:66666709-66666710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547087179 | chr13:66666710-66666711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs76248756 | chr13:66666714-66666715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs60615478 | chr13:66666741-66666742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs117124599 | chr13:66666781-66666782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531112703 | chr13:66666794-66666795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs144748710 | chr13:66666821-66666822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188017863 | chr13:66666827-66666828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530286206 | chr13:66666891-66666892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs145594059 | chr13:66666896-66666897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs115038569 | chr13:66666900-66666901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565808796 | chr13:66666902-66666903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs193091182 | chr13:66666917-66666918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs148553285 | chr13:66666921-66666922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571225214 | chr13:66666937-66666938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537361050 | chr13:66666944-66666945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377365778 | chr13:66666945-66666946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs184056483 | chr13:66666947-66666948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs35101782 | chr13:66666978-66666979 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs552880535 | chr13:66667008-66667009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573046172 | chr13:66667009-66667010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs545052778 | chr13:66667040-66667041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144418593 | chr13:66667052-66667053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76180051 | chr13:66667056-66667057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112432432 | chr13:66667069-66667070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs561661349 | chr13:66667085-66667086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530320614 | chr13:66667087-66667088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540869949 | chr13:66667095-66667096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557212225 | chr13:66667109-66667110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532843942 | chr13:66667163-66667164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs146624409 | chr13:66667186-66667187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551469151 | chr13:66667214-66667215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs202128361 | chr13:66667260-66667261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs188206699 | chr13:66667290-66667291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75207414 | chr13:66667298-66667299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs78112226 | chr13:66667299-66667300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200465515 | chr13:66667319-66667320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192153647 | chr13:66667331-66667332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550287711 | chr13:66667399-66667400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567589088 | chr13:66667413-66667414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs536151255 | chr13:66667414-66667415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs2767647 | chr13:66667534-66667535 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs566288649 | chr13:66667579-66667580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560637066 | chr13:66667599-66667600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Intellectual disability | 21811512 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 20877625 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:66660800-66662600 | Enhancers | Fetal Kidney | kidney |
2 | chr13:66666600-66667000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr13:66666800-66667000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr13:66666800-66667000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr13:66667000-66668600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr13:66668600-66668800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr13:66673200-66673600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr13:66673200-66673800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
9 | chr13:66673400-66674000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr13:66677000-66677400 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr13:66684600-66684800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr13:66688000-66688200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr13:66688000-66688600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr13:66688000-66688800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
15 | chr13:66688000-66688800 | Enhancers | NHDF-Ad | bronchial |
16 | chr13:66688200-66688400 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
17 | chr13:66688400-66688800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr13:66688400-66688800 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |